Lewis Stuart

2017 - NovaBay Pharmaceuticals

In 2017, Lewis Stuart earned a total compensation of $323.6K as Chief Commercial Officer at NovaBay Pharmaceuticals.

Compensation breakdown

Option Awards$264,384
Salary$25,000
Stock Awards$34,200
Total$323,584

Stuart received $264.4K in option awards, accounting for 82% of the total pay in 2017.

Stuart also received $25K in salary and $34.2K in stock awards.

Rankings

In 2017, Lewis Stuart's compensation ranked 13,155th out of 14,666 executives tracked by ExecPay. In other words, Stuart earned more than 10.3% of executives.

ClassificationRankingPercentile
All
13,155
out of 14,666
10th
Division
Manufacturing
5,176
out of 5,770
10th
Major group
Chemicals And Allied Products
1,877
out of 2,074
10th
Industry group
Drugs
1,564
out of 1,730
10th
Industry
Pharmaceutical Preparations
1,208
out of 1,329
9th
Source: SEC filing on April 18, 2018.

Stuart's colleagues

We found four more compensation records of executives who worked with Lewis Stuart at NovaBay Pharmaceuticals in 2017.

2017

Mark Sieczkarek

NovaBay Pharmaceuticals

Chief Executive Officer

2017

Justin Hall

NovaBay Pharmaceuticals

Secretary

2017

Thomas Paulson

NovaBay Pharmaceuticals

Chief Financial Officer

2017

John McGovern

NovaBay Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like